ArticleBMJ open2020

Medroxyprogesterone acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and endometrial carcinoma: trial protocol for a prospective, randomised, open, blinded-endpoint design, dose-response trial (FELICIA trial).

Akira Mitsuhashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.